These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2148195)

  • 1. Doxazosin in renal impairment.
    Waller DG; Oliver RM
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():47-9. PubMed ID: 2148195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of doxazosin in patients with hypertension and renal impairment.
    Oliver RM; Upward JW; Dewhurst AG; Honeywell R; Renwick AG; Waller DG
    Br J Clin Pharmacol; 1990 Apr; 29(4):417-22. PubMed ID: 2139337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of doxazosin on blood pressure and renal haemodynamics of hypertensive patients with renal failure.
    Bailey RR; Nairn PL; Walker RJ
    N Z Med J; 1986 Dec; 99(815):942-5. PubMed ID: 2949169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the efficacy and safety of doxazosin in the treatment of hypertension associated with renal insufficiency.
    Anderton JL; Notghi A
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():52-7. PubMed ID: 2148196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Lijnen P; Fagard R; Staessen J; Amery A
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.
    Miozzari M; Ambühl PM
    Nephrol Dial Transplant; 2004 Oct; 19(10):2615-21. PubMed ID: 15280521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doxazosin for the treatment of arterial hypertension].
    Mozzato MG; Semplicini A; Serena L; Valle R; Casolino P; Buzzaccarini F; Rubino N; Giusto M; Pessina AC
    Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of indoprofen in patients with renal insufficiency (a preliminary report).
    Wibell L; Nilsson P; Lindström B
    Eur J Rheumatol Inflamm; 1981; 4(1):16-21. PubMed ID: 7341276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of cyclosporine on renal function in organ transplant recipients.
    Bantle JP; Paller MS; Boudreau RJ; Olivari MT; Ferris TF
    J Lab Clin Med; 1990 Feb; 115(2):233-40. PubMed ID: 2405085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ceftazidime in normal and impaired renal function.
    Höffler D; Koeppe P; Williams KJ
    Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of increasing doses of nicorandil on renal function in man.
    Wolf DL; Jungbluth GL; Metzler CM; Froeschke MO; DeLoof MJ; Luderer JR
    Int J Clin Pharmacol Ther; 1994 May; 32(5):246-53. PubMed ID: 7921519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosin.
    Meredith PA; Elliott HL; Kelman AW; Vincent J; Reid JL
    Xenobiotica; 1988 Jan; 18(1):123-9. PubMed ID: 2895548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose and steady-state pharmacokinetics of doxazosin given in combination with chlorothiazide to hypertensive subjects.
    Conway EL; McNeil JJ; Meng L; Drummer OH; Howes LG; Raymond K; Louis WJ
    Clin Pharmacokinet; 1989 Jun; 16(6):387-91. PubMed ID: 2525447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients.
    Bragadottir G; Redfors B; Nygren A; Sellgren J; Ricksten SE
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1052-9. PubMed ID: 19572935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D; Koeppe P
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents.
    Louis WJ; McNeil JJ; Anavekar SN; Conway EL; Workman B; Howes LG; Drummer OH; Jarrott B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S100-3. PubMed ID: 2455158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxazosin, a case history.
    Campbell SF; Davey MJ
    Drug Des Deliv; 1986 Aug; 1(1):83-99. PubMed ID: 2978370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prazosin therapy on BP, renal function, and body fluid composition.
    Bauer JH; Jones LB; Gaddy P
    Arch Intern Med; 1984 Jun; 144(6):1196-200. PubMed ID: 6732379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.